Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$6.47 - $8.96 $71,965 - $99,662
-11,123 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$8.31 - $14.85 $14,376 - $25,690
-1,730 Reduced 13.46%
11,123 $103,000
Q1 2019

May 15, 2019

SELL
$10.01 - $13.89 $15,445 - $21,432
-1,543 Reduced 10.72%
12,853 $179,000
Q4 2018

Feb 14, 2019

BUY
$9.15 - $12.26 $131,723 - $176,494
14,396 New
14,396 $157,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.